Abstract:Future VirologyVol. 17, No. 8 EditorialAntisense protein: a novel HIV-1 gene requiring attentionXiaorui Zuo & Guangyong MaXiaorui ZuoInstitute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing, ChinaSearch for more papers by this author & Guangyong Ma *Author for correspondence: E-mail Address: gma@cpu.edu.cnhttps://orcid.org/0000-0002-2003-7201Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing, ChinaSearch for more papers by this authorPublished Online:19 Apr 2022https://doi.org/10.2217/fvl-2022-0008AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInRedditEmail View articleKeywords: ASPHBZHIVHTLVRNAReferences1. Ruelas DS, Greene WC. An integrated overview of HIV-1 latency. Cell 155(3), 519–529 (2013).Crossref, Medline, CAS, Google Scholar2. Elsheikh MM, Tang Y, Li D, Jiang G. Deep latency: a new insight into a functional HIV cure. EBioMedicine 45, 624–629 (2019).Crossref, Medline, Google Scholar3. Michael NL, Vahey MT, D'arcy L et al. Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat. J. Virol. 68(2), 979–987 (1994).Crossref, Medline, CAS, Google Scholar4. Landry S, Halin M, Lefort S et al. Detection, characterization and regulation of antisense transcripts in HIV-1. Retrovirology 4, 71 (2007).Crossref, Medline, Google Scholar5. Barbeau B, Mesnard JM. Does chronic infection in retroviruses have a sense? Trends Microbiol. 23(6), 367–375 (2015).Crossref, Medline, CAS, Google Scholar6. Miller RH. Human immunodeficiency virus may encode a novel protein on the genomic DNA plus strand. Science 239(4846), 1420–1422 (1988).Crossref, Medline, CAS, Google Scholar7. Briquet S, Vaquero C. Immunolocalization studies of an antisense protein in HIV-1-infected cells and viral particles. Virology 292(2), 177–184 (2002).Crossref, Medline, CAS, Google Scholar8. Vanhee-Brossollet C, Thoreau H, Serpente N, D'Auriol L, Levy JP, Vaquero C. A natural antisense RNA derived from the HIV-1 env gene encodes a protein which is recognized by circulating antibodies of HIV+ individuals. Virology 206(1), 196–202 (1995).Crossref, Medline, CAS, Google Scholar9. Affram Y, Zapata JC, Gholizadeh Z et al. The HIV-1 antisense protein ASP is a transmembrane protein of the cell surface and an integral protein of the viral envelope. J. Virol. 93(21), e00574–19 (2019).Crossref, Medline, Google Scholar10. Savoret J, Chazal N, Moles JP et al. A pilot study of the humoral response against the antisense protein (ASP) in HIV-1-infected patients. Front. Microbiol. 11, 20 (2020).Crossref, Medline, Google Scholar11. Bet A, Maze EA, Bansal A et al. The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection. Retrovirology 12, 15 (2015).Crossref, Medline, Google Scholar12. Berger CT, Llano A, Carlson JM et al. Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1. J. Virol. 89(7), 4015–4019 (2015).Crossref, Medline, CAS, Google Scholar13. Torresilla C, Larocque E, Landry S et al. Detection of the HIV-1 minus-strand-encoded antisense protein and its association with autophagy. J. Virol. 87(9), 5089–5105 (2013).Crossref, Medline, CAS, Google Scholar14. Liu Z, Torresilla C, Xiao Y et al. HIV-1 antisense protein of different clades induces autophagy and associates with the autophagy factor p62. J. Virol. 93(2), e01757–18 (2019).Crossref, Medline, Google Scholar15. Kobayashi-Ishihara M, Yamagishi M, Hara T et al. HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period. Retrovirology 9, 38 (2012).Crossref, Medline, CAS, Google Scholar16. Saayman S, Ackley A, Turner AW et al. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Mol. Ther. 22(6), 1164–1175 (2014).Crossref, Medline, CAS, Google Scholar17. Zapata JC, Campilongo F, Barclay RA et al. The human immunodeficiency virus 1 ASP RNA promotes viral latency by recruiting the polycomb repressor complex 2 and promoting nucleosome assembly. Virology 506, 34–44 (2017).Crossref, Medline, CAS, Google Scholar18. Kobayashi-Ishihara M, Terahara K, Martinez JP et al. HIV LTR-driven antisense RNA by itself has regulatory function and may curtail virus reactivation from latency. Front. Microbiol. 9, 1066 (2018).Crossref, Medline, Google Scholar19. Ma G, Yasunaga JI, Shimura K et al. Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence. Proc. Natl Acad.Sci. USA 118(17), e2014783118 (2021).Crossref, Medline, CAS, Google Scholar20. Mancarella A, Procopio FA, Achsel T et al. Detection of antisense protein (ASP) RNA transcripts in individuals infected with human immunodeficiency virus type 1 (HIV-1). J. Gen. Virol. 100(5), 863–876 (2019).Crossref, Medline, CAS, Google Scholar21. Chang ST, Sova P, Peng X et al. Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line. mBio 2(5), e00134–11 (2011).Crossref, Medline, Google Scholar22. Cassan E, Arigon-Chifolleau AM, Mesnard JM, Gross A, Gascuel O. Concomitant emergence of the antisense protein gene of HIV-1 and of the pandemic. Proc. Natl Acad. Sci. USA 113(41), 11537–11542 (2016).Crossref, Medline, CAS, Google Scholar23. Ma G, Yasunaga J, Matsuoka M. Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis. Retrovirology 13, 16 (2016).Crossref, Medline, Google Scholar24. Tomezsko P, Swaminathan H, Rouskin S. Viral RNA structure analysis using DMS-MaPseq. Methods 183, 68–75 (2020).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetails Vol. 17, No. 8 STAY CONNECTED Metrics Downloaded 75 times History Received 11 January 2022 Accepted 4 April 2022 Published online 19 April 2022 Published in print August 2022 Information© 2022 Future Medicine LtdKeywordsASPHBZHIVHTLVRNAFinancial & competing interests disclosureThis study was supported by the National Natural Science Foundation of China (no. 32070155 to G Ma) and a start-up fund from China Pharmaceutical University (no. 3154070031 to G Ma). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.No writing assistance was utilized in the production of this manuscript.PDF download

WHO Working Group on Characterization of HIV-Related Retroviruses: Criteria for Characterization and Proposal for a Nomenclature System

Type-specific and Cross-Reactive Neutralizing Antisera Against HIV Elicited by V3-peptide Heptalysine Octomers.

Sequence Characteristics of Hiv-1 B' Envelope Proteins and Its Potential Correlation with Broadly Neutralizing Activity

Semen-Mediated Enhancement of Hiv Infection Markedly Impairs the Antiviral Efficacy of Microbicides

AIDS Vaccine 2013october 7–10, 2013barcelona, Spain

Does Circumcision Offer Some Protection From Hiv For Men Who Have Sex With Men? A Cross-Sectional Study In China

HIV Type 1 B′/C Recombinant (CRF07_BC) in Virologic Noncontrollers Elicits Neutralizing Antibodies Against Heterologous but Not Autologous Viruses

OA3‐AM23‐ST‐13 | Multi‐Year Assessment of Antiretroviral Therapy Use among HIV Repeat Reactive US Blood Donors

Combined Approach of Vaccine and Antiviral Drugs Can Achieve Better Protection in Nhp Model Against Heterologous Shiv Challenges

An HIV Antibody Positive Plasma Donor Detected at the Early Stage of HIV Infection in China

Associations Between Human Leukocyte Antigen Polymorphisms and Hypersensitivity to Antiretroviral Therapy in Patients with Human Immunodeficiency Virus: a Meta-Analysis.

The Sexually Driven Epidemic in Youngsters of China's Southwestern Border Region Was Caused by Dynamic Emerging Multiple Recombinant HIV-1 Strains

Molecular Characterization of the 28 Kda Multigene Locus of Ehrlichia Muris.

Induction of Antibodies with Long Variable Heavy Third Complementarity Determining Regions by Repetitive Boosting with AIDSVAX® B/E in RV144 Vaccinees

[AIDS Study Group/Spanish AIDS Plan consensus document on antiretroviral therapy in adults with human immunodeficiency virus infection (updated January 2010)]

Irreversibly Skewed Development of B Cells Towards Terminal Stages During HIV-1 Infection and Resulted in Their Functional Impairment

Genetic Diversity of HIV-1 and Transfusion Safety : Systematic Review and Concepts Analysis

1406: Immune Sorting and Functional Identificationof Human Spermatogonial Stem Cells

Global and regional epidemiology of HIV-1 recombinants in 1990-2015: a systematic review and global survey

Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999–2023)

Antisense Protein: a Novel HIV-1 Gene Requiring Attention